This content is from:APP亚博娱乐
Amgen Raises $3B In Debt Issue
Amgen has raised $3 billion in a three-part sale of notes.
Amgenhas raised $3 billion in a three-part sale of notes,The Wall Street Journalreports. The $750 million notes, sold in the first tranche, carry a coupon rate of 2.3% and will mature in 2016, while the $1 billion notes, sold in the second part, carry a coupon rate of 4.10% and will mature in 2021.
The third tranche of $1.25 billion notes, which carry a coupon rate of 5.65%, are scheduled to mature in 2042. The California-based company will use the sale proceeds for general corporate purposes, including debt repayment, buying back shares and quarterly dividends. The biotechnology company appointedBarclays Capital,BofA Merrill LynchandMorgan Stanleyto lead the debt sale.
Click here for the story fromThe Wall Street Journal.
Click here for additional coverage fromBloomberg.